comparemela.com

Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer

Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

France ,Saint Antoine ,Aquitaine ,Paris ,France General ,Enterome Oncomimics ,Sylvie Berrebi Mark ,Romain Cohen ,Guillaume Bayre ,Head Of External Communications ,Professor Of Oncology At Sorbonne University Paris ,Health Science ,Minimal Residual Disease ,Assistant Professor ,Sorbonne University ,Coordinating Investigator ,Chief Executive Officer ,Mark Swallow ,Tumor Associated Antigens ,Universal Cancer Peptide ,

comparemela.com © 2020. All Rights Reserved.